Back
  1. Home
  2. Profile of Margaux Lejeune (ULiège)
Profil

Lejeune Margaux

Main Referenced Co-authors
Caers, Jo  (11)
Duray, Elodie  (10)
Beguin, Yves  (9)
Baron, Frédéric  (4)
Köse, Murat Cem  (4)
Main Referenced Keywords
multiple myeloma (4); CD38 (2); Humans (2); ADCC (1); Adult (1);
Main Referenced Unit & Research Centers
Laboratoire d'Hématologie (1)
Main Referenced Disciplines
Hematology (9)
Otolaryngology (2)
Oncology (1)
Radiology, nuclear medicine & imaging (1)

Publications (total 13)

The most downloaded
524 downloads
Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488. https://hdl.handle.net/2268/260541

The most cited

55 citations (Scopus®)

Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762 https://hdl.handle.net/2268/248987

Köse, M. C., Lejeune, M., Gou, M.-J., Duray, E., Cobraiville, G., Gothot, A., Beguin, Y., Fillet, M., & Caers, J. (15 November 2022). Integrative Analysis of Proteomics and Transcriptomics Reveals the Etrb As Novel Single Target and New Combinatorial Targets for Multiple Myeloma [Paper presentation]. ASH 2022 Symposium, New orleans, United States.

Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E., & D'Huyvetter, M. (2022). Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology, 13, 911080. doi:10.3389/fimmu.2022.911080
Peer Reviewed verified by ORBi

Vrancken, L., Lejeune, M., PIROTTE, M., Duray, E., Köse, M. C., BEGUIN, Y., & CAERS, J. (2021). Le myélome multiple : un tour d’horizon des nouveautés dans sa biologie et son traitement. Revue Médicale de Liège, 76, 482-488.
Peer reviewed

Lejeune, M., Duray, E., Peipp, M., Clémenceau, B., Baron, F., Beguin, Y., & Caers, J. (2021). Balancing the CD38 Expression on Effector and Target Cells in Daratumumab-Mediated NK Cell ADCC against Multiple Myeloma. Cancers, 13 (12), 3072. doi:10.3390/cancers13123072
Peer Reviewed verified by ORBi

Duray, E., Lejeune, M., Baron, F., Beguin, Y., Devoogdt, N., Krasniqi, A., Lauwers, Y., Zhao, Y. J., D'Huyvetter, M., Dumoulin, M., & Caers, J. (2021). A non-internalised CD38-binding radiolabelled single-domain antibody fragment to monitor and treat multiple myeloma. Journal of hematology & oncology, 14 (1), 183. doi:10.1186/s13045-021-01171-6
Peer reviewed

Lejeune, M., Köse, M. C., Duray, E., Einsele, H., Beguin, Y., & Caers, J. (07 May 2020). Bispecific, T-Cell-Recruiting Antibodies in B-Cell Malignancies. Frontiers in Immunology, 11 (762), 1-20. doi:10.3389/fimmu.2020.00762
Peer Reviewed verified by ORBi

Lejeune, M., Köse, M. C., Duray, E., Beguin, Y., & CAERS, J. (2020). Les anticorps bispécifiques ciblant les lymphocytes T dans le myélome multiple. OncoHemato : Revue Multidisciplinaire d'Oncologie et Hématologie, 14 (6), 30-34.
Peer reviewed

Bolomsky, A., Muller, J., Stangelberger, K., Lejeune, M., Duray, E., Breid, H., Vrancken, L., Pfeiffer, C., Hübl, W., Willheim, M., Weetall, M., Branstrom, A., Zojer, N., Caers, J., & Ludwig, H. (2020). The anti-mitotic agents PTC-028 and PTC596 display potent activity in pre-clinical models of multiple myeloma but challenge the role of BMI-1 as an essential tumour gene. British Journal of Haematology, 190, 877-890. doi:10.1111/bjh.16595
Peer Reviewed verified by ORBi

Muller, J., Duray, E., Lejeune, M., DUBOIS, S., Plougonven, E., Léonard, A., Storti, P., Giuliani, N., Cohen-Solal, M., Hempel, U., Thijssen, V., BEGUIN, Y., Heusschen, R., & CAERS, J. (2019). Loss of stromal galectin-1 enhances multiple myeloma development: Emphasis on a role in osteoclasts. Cancers, 11 (2), 261. doi:10.3390/cancers11020261
Peer Reviewed verified by ORBi

Muller, J., Bolomsky, A., Dubois, S., Duray, E., Stangelberger, K., Plougonven, E., Lejeune, M., Léonard, A., Marty, C., Hempel, U., Baron, F., BEGUIN, Y., Cohen-Solal, M., Ludwig, H., Heusschen, R., & CAERS, J. (2018). Maternal embryonic leucine zipper kinase inhibitor OTSSP167 has preclinical activity on multiple myeloma bone disease. Haematologica, 103, 1359-1368. doi:10.3324/haematol.2017.185397
Peer Reviewed verified by ORBi

Vrancken, L., Muller, J., Lejeune, M., Grégoire, C., Delens, L., Jaspers, A., Servais, S., DE PRIJCK, B., Baron, F., Caers, J., & Beguin, Y. (2018). Nouveautes dans la prise en charge du myelome. Revue Médicale Suisse, 14 (615), 1438-1442.
Peer Reviewed verified by ORBi

El-Shazly, A. E., Roncarati, P., Lejeune, M., Lefèbvre, P., & Delvenne, P. (2017). Tyrosine kinase inhibition is an important factor for gene expression of CRTH2 in human eosinophils and lymphocytes: A novel mechanism for explaining eosinophils recruitment by the neuro-immune axis in allergic rhinitis. International Immunopharmacology, 45 (45), 180-186. doi:10.1016/j.intimp.2017.02.015
Peer Reviewed verified by ORBi

Lejeune, M., LEFEBVRE, P., Delvenne, P., & El-Shazly, A. (2015). Nasal sodium cromoglycate (Lomusol) modulates the early phase reaction of mild to moderate persistent allergic rhinitis in patients mono-sensitized to house dust mite: A preliminary study. International Immunopharmacology, 26 (1), 272-6. doi:10.1016/j.intimp.2015.02.004
Peer Reviewed verified by ORBi

Contact ORBi